Stopping a manic episode with medication typically involves one or two core drugs: a mood stabilizer like lithium or valproate, an antipsychotic, or both. Most people see noticeable improvement within two to six days of starting treatment, though full resolution takes longer. The specific approach depends on how severe the episode is, whether psychotic symptoms are present, and what medications you may already be taking.
First-Line Medications for Acute Mania
Clinical guidelines recognize two main categories of medication for stopping a manic episode: mood stabilizers and atypical antipsychotics. For a first episode or for someone not currently on a maintenance regimen, the recommended first-line options as monotherapy include lithium, divalproex (a form of valproate), risperidone, quetiapine, aripiprazole, asenapine, and cariprazine. All of these have strong, replicated evidence showing they can bring mania under control.
When symptoms are severe or psychotic features are present (hallucinations, delusions, or paranoia), guidelines recommend combining an antipsychotic with a mood stabilizer rather than relying on one drug alone. This combination approach hits the episode from two angles: the antipsychotic works quickly to reduce agitation and disorganized thinking, while the mood stabilizer builds toward longer-term stability.
A second tier of medications, including olanzapine, haloperidol, ziprasidone, and carbamazepine, are also effective but carry less favorable side effect profiles. Olanzapine, for instance, is linked to significant weight gain, which is an even bigger concern for people with mood disorders who are already more susceptible to metabolic changes. Haloperidol works fast but comes with a higher risk of movement-related side effects.
How Quickly These Medications Work
The fastest-acting options are antipsychotics. Haloperidol, risperidone, and olanzapine can begin reducing manic symptoms within two to six days of starting treatment. This is faster than mood stabilizers alone, which is one reason antipsychotics are often the preferred first move when someone is in an acute crisis with significant agitation or impaired sleep.
Lithium, while highly effective, works on a slower timeline. It starts at a low dose and gets gradually increased over a period of weeks, with regular blood draws to check that levels are in the right range. For acute mania, the target blood concentration is 0.8 to 1.0 milliequivalents per liter in otherwise healthy adults, and slightly lower (0.6 to 0.8) in older adults or those with other medical conditions. Because lithium’s therapeutic window is narrow, meaning the helpful dose is close to the toxic dose, this careful titration is essential.
Divalproex can be ramped up more aggressively. A strategy called oral loading uses higher doses in the first two days to reach effective blood levels quickly. In one clinical trial, 84% of patients who received loading doses had therapeutic blood levels by day three, compared to only 30% of patients started on a standard gradual dose. This loading approach is considered safe and is often used when rapid response is a priority.
Managing Agitation and Sleeplessness
One of the most distressing features of mania is severe agitation and an inability to sleep, sometimes for days. Because the primary medications take at least a couple of days to kick in, short-acting sedatives are frequently used as a bridge. Lorazepam is the most commonly prescribed option in this role. In clinical trials of acute mania, roughly 79% of participants received lorazepam during the study period, with average doses around 2.2 mg per day during the first week to ten days.
These sedatives are not treating the mania itself. They’re buying time, calming the nervous system enough to allow sleep and reduce the risk of dangerous behavior while the core medications build to effective levels. They’re typically tapered off once the primary treatment gains traction.
In emergency settings where someone is severely agitated and unable to take oral medication, injectable antipsychotics can be administered. Intramuscular aripiprazole is one option that has been studied for acute agitation in both bipolar disorder and schizophrenia, with clinical monitoring over 24 hours to assess the response.
What Combination Therapy Looks Like
For moderate to severe episodes, the typical treatment path involves starting both a mood stabilizer and an antipsychotic at the same time, often with a short course of a sedative for agitation and sleep. The antipsychotic does the heavy lifting in the first week, bringing down the most acute symptoms. The mood stabilizer reaches its full therapeutic effect over the following weeks and becomes the backbone of ongoing treatment.
Once the episode resolves, the antipsychotic may be gradually reduced or discontinued while the mood stabilizer continues as maintenance therapy. Lithium has the strongest long-term evidence for preventing future episodes, which is why it’s often the drug that stays on board even after everything else is peeled away. Some people do best staying on a combination indefinitely, depending on how severe or frequent their episodes have been.
Why Blood Monitoring Matters
Both lithium and valproate require blood level monitoring, though for different reasons. Lithium’s narrow therapeutic index means that a blood level only slightly above the target can cause toxicity, with symptoms ranging from tremor and nausea to confusion and kidney problems. Regular blood draws, typically weekly during dose adjustments and less often once stable, are a non-negotiable part of lithium treatment.
Valproate monitoring is less critical from a safety standpoint, with a target range of 50 to 125 micrograms per milliliter. The guidelines note that serum level monitoring for valproate isn’t strictly mandatory, but it’s still useful for confirming you’re in the therapeutic range, especially if symptoms aren’t improving as expected.
Medications to Use With Caution
Not every medication that can treat mania is equally safe for every person. Clozapine, an older antipsychotic sometimes used in treatment-resistant cases, carries a rare but serious risk of a condition where white blood cell counts drop dangerously low. This risk led to the drug being pulled from the market for several years before being reintroduced with mandatory blood monitoring. It’s reserved for situations where other options have failed.
Ziprasidone stands out for an unusual reason: of all the atypical antipsychotics, it has the strongest association with potentially triggering manic symptoms in some patients, which is the opposite of what you want. Olanzapine is effective but causes more weight gain than other options, a particular concern given that people with bipolar disorder are already at elevated risk for metabolic problems. A newer formulation that combines olanzapine with another compound designed to limit weight gain may help offset this issue.
Antidepressants, while not covered in the acute mania guidelines as a treatment, are worth mentioning because they can worsen or trigger mania. If you’re taking an antidepressant when a manic episode begins, your prescriber will likely taper or stop it as part of the treatment plan.
What to Expect During Treatment
The first few days are often the hardest. Medications may cause drowsiness, dry mouth, or mild dizziness as your body adjusts. This is especially true of antipsychotics and sedatives, which are doing their job by slowing down an overstimulated brain. Sleep usually improves before mood fully normalizes, and that sleep itself is therapeutic.
Most people notice a meaningful reduction in racing thoughts, irritability, and grandiosity within the first week. Full stabilization, where your mood, energy, and judgment return to baseline, generally takes two to four weeks. During this period, you’ll likely have frequent check-ins with your prescriber, blood draws if you’re on lithium or valproate, and dose adjustments based on how you’re responding and what your lab results show.
The transition from acute treatment to maintenance is gradual. The goal isn’t just to stop this episode but to build a medication foundation that reduces the likelihood of the next one. That longer conversation, about which drugs to continue and at what doses, is one of the most important parts of bipolar disorder management.